SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer Article

authors

publication date

  • September 1, 2016

webpage

published in

keywords

  • And prognostic biomarkers
  • Clinicopathological predictors
  • Locally advanced and metastatic breast cancer
  • Needle biopsies
  • Neoadjuvant systemic therapies
  • SIAH E3 ligase
  • The RAS pathway activation in breast cancer

start page

  • 183

end page

  • 198

volume

  • 11